| Dr Thu Nguyen, MD | |
|
868 Ululani St, Suite 105, Hilo, HI 96720-3913 | |
| (808) 961-5522 | |
| (808) 961-0006 |
| Full Name | Dr Thu Nguyen |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 39 Years |
| Location | 868 Ululani St, Hilo, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831137447 | NPI | - | NPPES |
| 08743802 | Medicaid | HI | |
| 110236584 | Other | HI | RAILROAD MEDICARE |
| 00A0213692 | Other | HI | HMSA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 10125 (Hawaii) | Primary |
| Entity Name | Thu Nguyen , Md, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558476382 PECOS PAC ID: 0042218596 Enrollment ID: O20061117000320 |
News Archive
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Deakin University has been given World Health Organisation (WHO) Collaborating Centre status for research into obesity prevention and related nutrition and physical activity programs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thu Nguyen, MD 868 Ululani St, Suite 105, Hilo, HI 96720-3913 Ph: (808) 961-5522 | Dr Thu Nguyen, MD 868 Ululani St, Suite 105, Hilo, HI 96720-3913 Ph: (808) 961-5522 |
News Archive
Moerae Matrix Inc. announced today the initiation of its second Phase 1 clinical trial with MMI-0100, a first-in-class inhibitor of MAPKAP kinase 2 (MK2) that is being developed for pulmonary disorders characterized by inflammation and fibrosis. The study, conducted in the United Kingdom, is a double-blind, two-way cross-over design lipopolysaccharide (LPS) challenge study further evaluating the safety and tolerability of MMI-0100 when given via inhalation to healthy subjects who smoke.
It's long been known that people living with HIV experience a loss of white matter in their brains. As opposed to "gray matter," which is composed of the cell bodies of neurons, white matter is made up of a fatty substance called myelin that coats neurons, offering protection and helping them transmit signals quickly and efficiently.
Harvard University has granted a worldwide exclusive license to Sherlock Biosciences, Inc. to develop and commercialize technology from the Wyss Institute for Biologically Inspired Engineering to create a highly sensitive, nucleic acid-based diagnostic platform that can rapidly deliver accurate and inexpensive results for a vast range of needs in virtually any setting.
Deakin University has been given World Health Organisation (WHO) Collaborating Centre status for research into obesity prevention and related nutrition and physical activity programs.
› Verified 4 days ago
Dr. Jon V Martell, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 808-974-4700 | |
Dr. Douglas Hiroshi Yamashita, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1276 Kinoole St, Hilo, HI 96720 Phone: 808-935-7181 Fax: 808-935-6332 | |
Dr. Thomas C Chen, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1097 Apono Pl, Hilo, HI 96720 Phone: 808-959-6549 Fax: 808-959-6549 | |
Mrs. Joy Sakai Wilson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 808-932-3395 | |
Dr. Tiffany Ma, M.D., M.P.H Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1190 Waianuenue Ave, Hilo, HI 96720 Phone: 925-487-0372 | |
Dr. Anthony Lim, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1285 Waianuenue Ave, Hilo, HI 96720 Phone: 808-933-0625 Fax: 808-974-6864 | |
Dr. Pradeepta Chowdhury, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 670 Ponahawai St, Ste116, Hilo, HI 96720 Phone: 808-961-3404 Fax: 808-961-5460 |